GlassScriptPhysician profile
Kathy T Wilson
NPI 1114095841
$13,020.26
in general payments reported to CMS, 2019-2025
38 companies · $627 in 2025
The $627 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,501 · 2020: $3,759 · 2021: $5,114 · 2022: $1,434 · 2023: $234 · 2024: $350 · 2025: $627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $9,112.52 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Actelion Pharmaceuticals US, INC. | $1,123.43 | 2019-2022 | |
| Glaxosmithkline, LLC. | $578.57 | 2019-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $369.13 | 2019-2025 | Ofev |
| Inspire Medical Systems, INC. | $209.23 | 2023-2025 | Inspire |
| Philips North America LLC | $145.90 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $126.86 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $118.89 | 2019-2024 | Yupelri |
| Harmony Biosciences LLC | $100.61 | 2024 | |
| Sunovion Pharmaceuticals INC. | $93.23 | 2019-2020 | |
| Amgen INC. | $88.62 | 2023-2025 | Tezspire |
| Abbvie INC. | $66.94 | 2021-2023 | Avycaz |
| Insmed, INC. | $64.14 | 2019-2021 | |
| United Therapeutics Corporation | $60.65 | 2019-2021 | |
| Baxter Healthcare | $60.20 | 2022-2023 | Hillrom - Volara System |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathy Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.